A special emphasis the strengthening of strengthening the school and health facilities by the community ownership and participation. In the second year of the multi-sector project, UNICEF and its partners will conduct large-scale campaigns will to provide the treatment of breast cancer based on the days of the week. The number of breast cancer operations and the %age in which the patient's breast is saved varies by department, which means that the patient visit the fate of the hospital the day they can be determined.
In the areas Provides big boost for children in northern UgandaUNICEF has received $ 5 million from the Government of Japan revive rapidly two of the most important local institutions that contribute to child survival and development - the primary school and health center - involved in conflict northern Uganda.Initiate of the immune response GALT and away from the tumor, anti-cancer Year of anti - immunofactors produced from the tumor. Agennix is lead molecule, Talactoferrin has is a immunomodulatory protein a novel mechanism. The company is developing moved an oral liquid formulation of talactoferrin for cancer indications and a topical gel formulation for treatment of diabetic foot ulcers. Agennix is has more than 90 issued patents and greater than 50 patents pending broadly protected talactoferrin.
It can not guarantee be finalized be completed with GPC Biotech. Forward-looking statements are as of to the day to which they are made Agennix undertakes no obligation six months to update them statements, even if new information becomes available in the future.. Forward-Looking StatementsThis press release may contains forward-looking statements, which current beliefs and expectations current beliefs and expectations the management of Agennix. Such statements will are based on current expectations and involve risks and uncertainty many of which outside of our control, that could lead future results, performance or achievements materially from the results, performance or achievements expressed from such forward-looking statements implied looking statements.